Drug/Medical Device

Amgen, Inc. (AMGN)

More Information:

Learn more about Drug/Medical Device Reports.

Date: Jan 27, 2007
Format: PDF
View Report »

Abstract

The Amgen, Inc. (AMGN) Drug/Medical Device report provides unparalleled insights into its performance and risk through making available 3 key pieces of data: (1) product/candidate pipeline, (2) product/candidate regulatory status, and (3) product/candidate pipeline diversification. The report includes a detailed presentation of each drug/device candidate's indication, its clinical trial status (i.e. preclinical, Phase 1, Phase 2, Phase 3, NDA/BLA Filed, IDE Filed, 510K/PMA Filed, Approvable Letter Received), and its mechanism of action. In addition, the report identifies the strategic disease focus of Amgen, Inc. and outlines its pipeline diversification across various disease sectors and sub-sectors (i.e. Cardiology, Oncology, Neurology, Immunology, Urology, etc.).

Report Contents

  • Overview
    • Product Summary
    • Business Description
    • Technical Summary
    • Company Highlights
  • Drug/Medical Device Details
    • Industry/Sector Participation
    • Product details
    • Indications/Side Effects/Approval Details

Companies Mentioned in the Report